Toward Better Understanding of Insulin Therapy by Translation of a PK-PD Model to Visualize Insulin and Glucose Action Profiles

Journal of Clinical Pharmacology
Karen B SchneckJesus Reviriego

Abstract

Insulin replacement therapy is a fundamental treatment for glycemic control for managing diabetes. The engineering of insulin analogues has focused on providing formulations with action profiles that mimic as closely as possible the pattern of physiological insulin secretion that normally occurs in healthy individuals without diabetes. Hence, it may be helpful to practitioners to visualize insulin concentration profiles and associated glucose action profiles. Expanding on a previous analysis that established a pharmacokinetic (PK) model to describe typical profiles of insulin concentration over time following subcutaneous administration of various insulin formulations, the goal of the current analysis was to link the PK model to an integrated glucose-insulin (IGI) systems pharmacology model. After the pharmacokinetic-pharmacodynamic (PK-PD) model was qualified by comparing model predictions with clinical observations, it was used to project insulin (PK) and glucose (PD) profiles of common insulin regimens and dosing scenarios. The application of the PK-PD model to clinical scenarios was further explored by incorporating the impact of several hypothetical factors together, such as changing the timing or frequency of administrati...Continue Reading

References

Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert
Sep 10, 2003·Journal of the American Dietetic Association·David C FrankenfieldR N Cooney
Mar 6, 2004·Journal of Pharmacokinetics and Pharmacodynamics·Liping ZhangLewis B Sheinerz
Jan 14, 2005·The New England Journal of Medicine·Irl B Hirsch
Jul 18, 2006·Diabetic Medicine : a Journal of the British Diabetic Association·P Roach, J K Malone
Oct 2, 2007·Journal of Clinical Pharmacology·Petra M JauslinMats O Karlsson
Jun 10, 2008·Diabetes Care·David M NathanUNKNOWN A1c-Derived Average Glucose Study Group
Jan 7, 2010·Basic & Clinical Pharmacology & Toxicology·Hanna E SilberMats O Karlsson
Mar 12, 2010·Journal of Clinical Pharmacology·Petra M JauslinMats O Karlsson
Feb 18, 2012·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Wei Gao, William J Jusko
Oct 10, 2012·Expert Opinion on Biological Therapy·Katherine EspositoDario Giugliano
Feb 25, 2014·Journal of Diabetes and Metabolic Disorders·Muhammad Yakoob AhmedaniAbdul Basit
Mar 31, 2015·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Robert C HoodJeffrey A Jackson
Aug 1, 2015·CPT: Pharmacometrics & Systems Pharmacology·J WojciechowskiR N Upton
Sep 19, 2015·Canadian Journal of Surgery. Journal Canadien De Chirurgie·Daniel WalthoAchilleas Thoma
Feb 5, 2016·CPT: Pharmacometrics & Systems Pharmacology·W WangD A James
Sep 24, 2016·Nature Materials
Apr 11, 2017·Journal of Clinical Pharmacology·Lai San ThamJesus Reviriego
Oct 25, 2017·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Nicolaas C SchaperMette Bøgelund
Mar 24, 2018·Journal of Diabetes Science and Technology·Iman HajizadehAli Cinar
Nov 18, 2018·The Lancet. Diabetes & Endocrinology· The Lancet Diabetes Endocrinology

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Methods Mentioned

BETA
pharmacotherapy
ISS

Software Mentioned

R
RxODE
NONMEM
R browser toolkit
Shiny

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.